Evaluating a New International Risk-Prediction Tool in IgA Nephropathy

IMPORTANCE: Although IgA nephropathy (IgAN) is the most common glomerulonephritis in the world, there is no validated tool to predict disease progression. This limits patient-specific risk stratification and treatment decisions, clinical trial recruitment, and biomarker validation. OBJECTIVE: To der...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JAMA Intern Med
Hlavní autoři: Barbour, Sean J., Coppo, Rosanna, Zhang, Hong, Liu, Zhi-Hong, Suzuki, Yusuke, Matsuzaki, Keiichi, Katafuchi, Ritsuko, Er, Lee, Espino-Hernandez, Gabriela, Kim, S. Joseph, Reich, Heather N., Feehally, John, Cattran, Daniel C.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Medical Association 2019
Témata:
Original Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583088/
https://ncbi.nlm.nih.gov/pubmed/30980653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2019.0600
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky